54197-66-9: Cilostazol Related Compound A

54197-66-9: Cilostazol Related Compound A

It is an impurity present in Cilostazol. Cilostazol is a quinolinone derivative and antiplatelet agent have metabolites are cyclic AMP phosphodiesterase III inhibitors, inhibiting phosphodiesterase activity and suppressing cAMP degradation with a resultant increase in cAMP in platelets and blood vessels. cause inhibition of platelet aggregation and vasodilation. also reduces the symptoms of intermittent claudication as indicated by an increased walking distance.

Additional information on CAS 54197-66-9

Catalogue No.

VE006096
CAS No.

54197-66-9
Molecular Formula

C9H9NO2
Molecular Weight

163.17
Parent drug

Cilostazol
IUPAC Name

3, 4-Dihydro-6-hydroxy-2(1H)-quinolinone
Synonyms

N/A
References

Chi, Y.-W. (2008). Safety and efficacy of cilostazol in the management of intermittent claudication. Vascular Health and Risk Management, Volume 4, 1197–1203. https://doi.org/10.2147/vhrm.s3160
Status

In-stock

Other products related to cilostazol

[rfq_list]

Login first to add product to RFQ List

Request a quote

54197-66-9: Cilostazol Related Compound A

54197-66-9: Cilostazol Related Compound A
Catalogue No.

VE006096
CAS No.

54197-66-9
Molecular Formula

C9H9NO2
Molecular Weight

163.17
Parent drug

Cilostazol
IUPAC Name

3, 4-Dihydro-6-hydroxy-2(1H)-quinolinone
Synonyms

N/A
References

Chi, Y.-W. (2008). Safety and efficacy of cilostazol in the management of intermittent claudication. Vascular Health and Risk Management, Volume 4, 1197–1203. https://doi.org/10.2147/vhrm.s3160
Status

In-stock
ListName

Cilostazol Related Compound A
Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden